Coalson J J, Winter V, Yang F
Department of Pathology, The University of Texas Health Science Center at San Antonio, 78284, USA.
Anat Rec. 1998 Mar;250(3):300-15. doi: 10.1002/(SICI)1097-0185(199803)250:3<300::AID-AR5>3.0.CO;2-3.
There are disparate reports concerning the presence of surfactant proteins in the airways of lung. The recent finding of SP-A in tracheobronchial epithelium and submucosal glands in lungs from second trimester humans has renewed interest in potential new functions of surfactant in lung biology.
In situ hybridization studies were done to determine the distribution of SP-A, SP-B, and SP-C in baboon lung specimens from 60, 90, 120, 140, 160, and 180 (term) days of gestation and adults. Lungs from gestation controls were obtained at the time of hysterotomy and adult lungs at necropsy. Riboprobes used for in situ hybridization contained the entire coding regions for human SP-A, SP-B, and SP-C.
At 60 days, SP-C mRNA expression was evident in focal portions of primitive tubular epithelium but not bronchi. This distal pattern of SP-C mRNA expression persisted and was present in some epithelial cells of respiratory bronchioles at term. At 90 days, SP-A mRNA expression was present in the epithelium of trachea and large bronchi. SP-B mRNA expression was found in small bronchi, bronchioles, and distal tubular epithelium at 120 days of gestation. SP-A mRNA bronchiolar localization became evident at 140 days of gestation and alveolar type 2 cellular expression at 160 days of gestation. Abrupt transitions of surfactant protein expression were identified (e.g., SP-A mRNA-positive cells in the epithelium of large bronchi with adjoining SP-B mRNA expression in small bronchi and bronchioles).
Findings in the baboon indicate that there are well-delineated sites of surfactant protein mRNA expression in bronchial and bronchiolar epithelia. mRNA expressions of SP-A and SP-B are present in both bronchial and bronchiolar epithelium but at different sites, whereas SP-C expression is seen in loci of epithelial cells in respiratory bronchioles.
关于肺气道中表面活性物质蛋白的存在情况,有不同的报道。最近在孕中期人类肺脏的气管支气管上皮和黏膜下腺中发现了SP-A,这重新引发了人们对表面活性物质在肺生物学中潜在新功能的兴趣。
进行原位杂交研究,以确定妊娠60、90、120、140、160和180(足月)天的狒狒肺标本以及成年狒狒肺中SP-A、SP-B和SP-C的分布。妊娠对照组的肺在子宫切开术时获取,成年肺在尸检时获取。用于原位杂交的核糖探针包含人SP-A、SP-B和SP-C的完整编码区。
在60天时,SP-C mRNA表达在原始管状上皮的局灶部分明显,但支气管中没有。这种SP-C mRNA表达的远端模式持续存在,足月时在呼吸性细支气管的一些上皮细胞中也有。在90天时,SP-A mRNA表达存在于气管和大支气管的上皮中。在妊娠120天时,在小支气管、细支气管和远端管状上皮中发现了SP-B mRNA表达。在妊娠140天时,SP-A mRNA在细支气管中的定位变得明显,在妊娠160天时,在Ⅱ型肺泡细胞中有表达。确定了表面活性物质蛋白表达的突然转变(例如,大支气管上皮中的SP-A mRNA阳性细胞与小支气管和细支气管中相邻的SP-B mRNA表达)。
狒狒的研究结果表明,在支气管和细支气管上皮中有明确界定的表面活性物质蛋白mRNA表达位点。SP-A和SP-B的mRNA表达存在于支气管和细支气管上皮中,但位置不同,而SP-C表达见于呼吸性细支气管上皮细胞的位点。